GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

Cancer risk in men depends on both genetics and lifestyle, with factors like smoking, diet, and exercise playing significant ...

In recent decades, as rates of obesity have soared around the world, beverage giant Coca-Cola and its industry peers have ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

Eating breakfast regularly has been shown to help reduce the risk of developing type 2 diabetes, cardiovascular disease and obesity, according to UC Davis Health. There is also evidence that eating a ...

The skyrocketing popularity of weight-loss drugs is fast becoming a state budgetary concern. Policymakers must choose between ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

The National Bariatric Center (NBC) of the Qatar Metabolic Institute (QMI) at Hamad Medical Corporation (HMC) has earned ...

Read about the top 15 political, economic, social, environmental, technology and industry trends that will shape 2025 and ...